Published in Organogenesis on October 01, 2008
Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. J Thorac Cardiovasc Surg (2015) 2.43
Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. J Biol Chem (2010) 1.09
Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis (2011) 1.00
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Front Immunol (2015) 0.93
Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke. Biomatter (2013) 0.87
Serum analyses for protein, albumin and IL-1-RA serve as reliable predictors for seroma formation after incisional hernia repair. Hernia (2011) 0.87
Hyaluronan synthase mediates dye translocation across liposomal membranes. BMC Biochem (2012) 0.84
Hyaluronan regulation of endothelial barrier function in cancer. Adv Cancer Res (2014) 0.83
Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold. J Cell Mol Med (2013) 0.83
Hyaluronic acid stimulates neovascularization during the regeneration of bone marrow after ablation. J Biomed Mater Res A (2011) 0.83
Revascularization of decellularized lung scaffolds: principles and progress. Am J Physiol Lung Cell Mol Physiol (2015) 0.81
Effects of human bone marrow mesenchymal stem cells on burn injury healing in a mouse model. Int J Clin Exp Pathol (2013) 0.81
Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage. Tissue Eng Part A (2013) 0.78
Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling. Histochem Cell Biol (2012) 0.78
Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells. Theranostics (2015) 0.78
A biomimetic approach to active self-microencapsulation of proteins in PLGA. J Control Release (2014) 0.77
Encapsulation of PEGylated low-molecular-weight PEI polyplexes in hyaluronic acid hydrogels reduces aggregation. Acta Biomater (2015) 0.77
Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative. J Artif Organs (2013) 0.76
Human skin cell fractions fail to self-organize within a gellan gum/hyaluronic acid matrix but positively influence early wound healing. Tissue Eng Part A (2014) 0.75
The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics. Microorganisms (2017) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Tissue engineering. Science (1993) 19.65
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 9.51
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 8.24
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 6.47
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Angiogenesis induced by degradation products of hyaluronic acid. Science (1985) 3.37
Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol (2008) 3.24
Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem (2004) 2.81
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol (1994) 2.63
Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol (1988) 2.41
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell (1989) 2.27
Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood (2004) 2.21
Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng (2003) 2.17
The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials (2004) 2.12
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest (1984) 2.04
Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol (2002) 1.93
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev (2006) 1.92
Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J (2001) 1.91
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci U S A (2003) 1.90
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86
Mammalian hyaluronan synthases. IUBMB Life (2002) 1.85
Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol (2004) 1.82
Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol (2006) 1.79
The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res (1989) 1.67
Implantable biohybrid artificial organs. Cell Transplant (1995) 1.65
Mechanisms of angiogenesis. Biochemistry (Mosc) (2008) 1.63
Angiogenesis in wound healing. Pharmacol Ther (1991) 1.62
Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem (2001) 1.60
Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer (1997) 1.51
Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem (2002) 1.50
Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res (1999) 1.41
Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene (2003) 1.41
Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A (2003) 1.41
The role of hyaluronan in tumour neovascularization (review). Int J Cancer (1995) 1.40
The pathophysiology of angiogenesis. Crit Rev Oral Biol Med (1995) 1.34
Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem (2000) 1.34
Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials (2005) 1.33
Hyaluronan and angiogenesis. Ciba Found Symp (1989) 1.33
Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest (1998) 1.32
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res (1997) 1.28
Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res (2003) 1.26
Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol (2007) 1.22
A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res (2006) 1.21
Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys (2001) 1.20
Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury. J Neurosurg Spine (2004) 1.18
Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol (2006) 1.14
Synthesis and characterization of polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications. J Biomed Mater Res (2000) 1.14
Decreasing the metastatic potential in cancers--targeting the heparan sulfate proteoglycans. Curr Drug Targets (2005) 1.14
Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials (2004) 1.13
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation (1986) 1.10
In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update (2007) 1.10
Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem (2008) 1.09
Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ Res (2006) 1.09
The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. Biochem J (1986) 1.09
Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials (2006) 1.08
Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med (1985) 1.08
Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther (2004) 1.07
Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol (1994) 1.06
Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med (2003) 1.06
Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials (2005) 1.05
Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng (2006) 1.05
Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res (1999) 1.05
Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg (2005) 1.04
Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release (2005) 1.03
Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol (1987) 1.02
Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation (1999) 1.01
Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res (2002) 1.00
Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest (1996) 1.00
Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Invest Med (2008) 0.99
A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells. Biomaterials (2006) 0.98
Adipose tissue engineering in vivo with adipose-derived stem cells on naturally derived scaffolds. J Biomed Mater Res A (2009) 0.98
Systems for therapeutic angiogenesis in tissue engineering. World J Urol (2000) 0.98
Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol (2005) 0.96
Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A (2004) 0.96
Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem (2003) 0.96
The pathogenesis of hemangiomas: a review. Plast Reconstr Surg (2006) 0.96
Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest (1995) 0.95
Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells. FASEB J (2005) 0.95
Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials (2007) 0.93
In vivo engineering of a human vasculature for bone tissue engineering applications. J Cell Mol Med (2009) 0.92
Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical. Pathophysiology (2003) 0.92
Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials (2007) 0.92
Hyaluronan and human endothelial cell behavior. Connect Tissue Res (2008) 0.91
Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med (2008) 0.91
Acellular biological tissues containing inherent glycosaminoglycans for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng (2006) 0.90
Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle. Biol Reprod (2003) 0.90
Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen (2006) 0.89
Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. Curr Pharm Des (2007) 0.89
Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. Acta Pharmacol Sin (2007) 0.89
Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther (2006) 0.89
Dermatological aspects of angiogenesis. Br J Dermatol (2002) 0.88
Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J Biochem (2004) 0.88
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials (2006) 1.19
In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials (2005) 1.18
Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials (2006) 1.15
Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A (2009) 1.06
Benefits of concurrent delivery of hyaluronan and IGF-1 cues to regeneration of crosslinked elastin matrices by adult rat vascular cells. J Tissue Eng Regen Med (2008) 0.99
A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells. Biomaterials (2006) 0.98
Lysyl oxidase enhances elastin synthesis and matrix formation by vascular smooth muscle cells. J Tissue Eng Regen Med (2009) 0.93
Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng Part A (2011) 0.92
Biomimetic regeneration of elastin matrices using hyaluronan and copper ion cues. Tissue Eng Part A (2009) 0.92
Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly. Tissue Eng Part B Rev (2012) 0.92
Implantation of a skin graft tube to create a saphenoperitoneal shunt for refractory ascites. Surg Today (2007) 0.92
Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med (2008) 0.91
Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair. Acta Biomater (2009) 0.88
Copper nanoparticle cues for biomimetic cellular assembly of crosslinked elastin fibers. Acta Biomater (2008) 0.88
Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. Acta Biomater (2013) 0.87
Impact of pre-existing elastic matrix on TGFβ1 and HA oligomer-induced regenerative elastin repair by rat aortic smooth muscle cells. J Tissue Eng Regen Med (2011) 0.87
The impact of hyaluronic acid oligomer content on physical, mechanical, and biologic properties of divinyl sulfone-crosslinked hyaluronic acid hydrogels. J Biomed Mater Res A (2010) 0.85
Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells. Tissue Eng Part A (2009) 0.85
Induced elastic matrix deposition within three-dimensional collagen scaffolds. Tissue Eng Part A (2011) 0.85
Effects of gamma-irradiation on physical and biologic properties of crosslinked hyaluronan tissue engineering scaffolds. Tissue Eng (2007) 0.82
Nanoparticles for localized delivery of hyaluronan oligomers towards regenerative repair of elastic matrix. Acta Biomater (2013) 0.81
Evaluating smooth muscle cells from CaCl2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells. Tissue Eng Part A (2011) 0.81
Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res (2012) 0.78
Impact of electrospun conduit fiber diameter and enclosing pouch pore size on vascular constructs grown within rat peritoneal cavities. Tissue Eng Part A (2012) 0.78
Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression. Int J Neuropsychopharmacol (2013) 0.77
Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms. Stem Cells Transl Med (2013) 0.77
Composition of intraperitoneally implanted electrospun conduits modulates cellular elastic matrix generation. Acta Biomater (2013) 0.77
Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum (2002) 0.77
Impact of cyclic stretch on induced elastogenesis within collagenous conduits. Tissue Eng Part A (2014) 0.76